The core of Genefill is defined by Advanced Thixotropic Technology (ATT), which determines how gel molecules behave during and after injection to ensure a smooth application and strong stability degree.
Thanks to a special manufacturing process, thixotropic molecules in Genefill gel have the ability to become less viscous under the injecting pressure. This process provides highly stable cross-linked HA molecules allowing an injection with a reduced force and thinner needles, minimizing the pain level and giving the patient an optimal treatment comfort.
Hyaluronic acid molecules in conventional gels tend to permanently break down when exposed to injecting pressure, which negatively impacts fillers’ duration and their efficacy in the dermis.Molecules with enhanced thixotropic behavior in Genefill gels, return to their original viscosity when pressure from the syringe is released, which results in a long-lasting and stable effect.
BioScience GmbH is a German manufacturer designing and producing medical devices based on hyaluronic acid.
As of today, they are one of the few manufacturers to offer both monophasic and biphasic dermal fillers.
Committed to helping people in maintaining a youthful appearance and ultimately improving their overall quality of life.
Our knowledge and experience have brought us the trust of the most recognized plastic surgeons and dermatologists worldwide.